Eli Lilly (LLY) FY2012 results: revenue $22.6 billion, down 6.9% on the year
Eli Lilly & Co. (LLY) reported revenue of $22.6 billion for fiscal 2012, the year ended 31 December 2012, down 6.9% on the year before. Net income was $4.1 billion, down 6.0%, and diluted earnings per share $3.66. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2013.
Revenue
$22.6 billion
-6.9% on the year
FY2007FY2012
Operating margin
n/a
FY2007FY2012
Net income
$4.1 billion
-6.0% on the year
FY2007FY2012
Diluted EPS
$3.66
-6.2% on the year
FY2007FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
22,603
24,286
23,076
-6.9%
Cost of revenue
4,796
5,068
4,366
-5.4%
Gross profit
17,807
19,219
18,710
-7.3%
Gross margin
78.8%
79.1%
81.1%
Research and development
5,278
5,021
4,884
+5.1%
Selling, general and administrative
7,514
7,880
7,053
-4.6%
Interest expense
178
186
186
-4.4%
Pre-tax income
4,902
6,139
6,767
-20.2%
Income tax
1,320
1,002
1,456
+31.7%
Effective tax rate
26.9%
16.3%
21.5%
Net income
4,089
4,348
5,070
-6.0%
Net margin
18.1%
17.9%
22.0%
Diluted EPS
$3.66
$3.90
$4.58
-6.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
5,305
7,234
6,857
-26.7%
Capital expenditure
905
672
694
+34.7%
Free cash flow
4,399
6,562
6,162
-33.0%
Free cash flow margin
19.5%
27.0%
26.7%
Cash from investing
-2,833
-4,824
-3,160
Cash from financing
-4,420
-2,370
-2,022
Depreciation and amortisation
1,462
1,374
1,328
+6.5%
Share-based compensation
142
147
231
-4.0%
Buybacks
721
0.0
0.0
Dividends paid
2,187
2,180
2,165
+0.3%
Dividend per share
n/a
$1.96
$1.96
Diluted shares, weighted
1,117m
1,114m
1,106m
+0.3%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
14,765
13,542
12,420
+9.0%
Non-controlling interest
8.7
-6.1
-7.5
Short-term borrowings
11.9
1,522
n/a
-99.2%
Debt
5,531
6,982
6,926
-20.8%
Other liabilities
14,082
11,620
11,662
+21.2%
Total liabilities and equity
34,399
33,660
31,001
+2.2%
Fixed assets
7,760
7,760
7,941
-0.0%
Goodwill
1,501
1,435
1,424
+4.6%
Intangible assets
3,186
n/a
n/a
Investments
7,979
5,004
2,513
+59.4%
Cash and equivalents
4,019
5,922
5,993
-32.1%
Receivables
3,336
3,598
3,494
-7.3%
Inventory
2,644
2,300
2,518
+15.0%
Other assets
3,973
7,640
7,119
-48.0%
Total assets
34,399
33,660
31,001
+2.2%
10-K for the year ended 31 December 2012, filed 21 February 2013: the filing.